Rare diseases
Investigational molecules
Locations
Martin Linges Vei 25, 1364, Norway
Softox Solutions AS focuses on chronic airway infections, with research centered on patients affected by persistent bacterial burden in the respiratory tract. Its clinical activity includes work in cystic fibrosis, primary ciliary dyskinesia, and non-cystic fibrosis bronchiectasis, reflecting interest in difficult-to-treat infectious disease settings within pulmonary medicine.
The sponsor’s research interest is directed toward inhaled treatment approaches for reducing bacterial load in the lower airways and addressing persistent infection-related symptoms in chronic respiratory disease.
Softox Solutions AS runs clinical trials in conditions such as Respiratory tract infection, among others.
Clinical trials run by this sponsor – those enrolling participants first.
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
